Conservative MP Andrew Bridgen has called for the mRNA covid vaccine to be suspended as he claimed that a report linking heart problems with the MRA Covid vaccine has been suppressed by a senior cardiologist who has “a leadership role with the British Heart Foundation”. The North West Leicestershire MP used an end of day adjournment debate to make his claims on the floor of the House of Commons that problems with the vaccine are being covered up because of financial links with “Big Pharma.” The claims have been denied by the charity.
Quoting Richard Smith, the former editor of the British Medical Journal, he said: “Research misconduct is rife and not effectively been tackled. Something is rotten in British medicine and it has been for a long time.”
The MP then turned to his biggest claim that a report linking inflammation to the arteries and the vaccine had been deliberately suppressed.
He said: “It has been brought to my attention by a whistleblower from a very reliable source that one of these institutions is covering up clear data that reveals that the mRNA vaccine increased inflammation of the heart arteries.
“They are covering this up in fear that they may lose funding from the pharmaceutical industry.
“The leader of that cardiology research department has a prominent leadership role with the British Heart Foundation and I am very disappointed to say that he has sent out non-disclosure agreements to his research team to ensure that this important data never sees the light of day.
“This is an absolute disgrace. Systemic failure in an over-medicated population also contributes to huge waste of British taxpayers’ money and is an increasing strain on the NHS.”
The Prime Minister vowed to turn away Albanians more swiftly, clear the backlog of asylum claims by the end of next year and make the Rwanda deportation plan work.
He also promised to end the use of hotels to house asylum seekers at a cost to taxpayers of £5.5 million a day by switching to disused holiday parks, former student halls and unoccupied military sites.